Concepedia

CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel

Marjan Aghajani, Ahad Mokhtarzadeh, Leili Aghebati‐Maleki, Behzad Mansoori, Ali Mohammadi, Sahar Safaei, Zahra Asadzadeh, Khalil Hajiasgharzadeh, Vahid Khaze, Behzad Baradaran

Molecular Biology Reports · 2020 · 26 citations · 38 references

DOI

Concepts

References

38

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

, , +16

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Ting‐Chao Chou, Paul Talalay · Advances in Enzyme Regulation · 1984 · 7.2K citations

, , +16

Prospective Identification of Tumorigenic Prostate Cancer Stem Cells

Anne T. Collins, Paul A. Berry, Catherine Hyde et al. · Cancer Research · 2005 · 2.8K citations

, , +17

CD133, a novel marker for human prostatic epithelial stem cells

Gavin D. Richardson, Craig Robson, Shona Lang et al. · Journal of Cell Science · 2004 · 764 citations · Full text

, , +17

Synchronous Bursts on Scale-Free Neuronal Networks with Attractive and Repulsive Coupling

Qingyun Wang, Guanrong Chen, Matjaž Perc · PLoS ONE · 2011 · 478 citations · Full text

, , +16